Compare SUVEN LIFE with Sun Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFESCIENCES vs SUN PHARMA - Comparison Results

SUN PHARMA 
   Change

Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFESCIENCES SUN PHARMA SUVEN LIFESCIENCES/
SUN PHARMA
 
P/E (TTM) x 4.2 27.4 15.3% View Chart
P/BV x 0.6 2.8 22.3% View Chart
Dividend Yield % 3.7 0.6 643.9%  

Financials

 SUVEN LIFESCIENCES   SUN PHARMA
EQUITY SHARE DATA
    SUVEN LIFESCIENCES
Mar-19
SUN PHARMA
Mar-19
SUVEN LIFESCIENCES/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs338679 49.7%   
Low Rs169375 45.1%   
Sales per share (Unadj.) Rs52.1121.1 43.0%  
Earnings per share (Unadj.) Rs6.813.4 51.1%  
Cash flow per share (Unadj.) Rs8.620.7 41.4%  
Dividends per share (Unadj.) Rs1.502.75 54.5%  
Dividend yield (eoy) %0.60.5 113.4%  
Book value per share (Unadj.) Rs65.3172.6 37.8%  
Shares outstanding (eoy) m127.282,399.26 5.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.94.4 111.8%   
Avg P/E ratio x37.139.4 94.2%  
P/CF ratio (eoy) x29.625.5 116.1%  
Price / Book Value ratio x3.93.1 127.2%  
Dividend payout %22.020.6 106.8%   
Avg Mkt Cap Rs m32,2721,264,650 2.6%   
No. of employees `0001.117.5 6.2%   
Total wages/salary Rs m66159,671 1.1%   
Avg. sales/employee Rs Th6,132.216,608.1 36.9%   
Avg. wages/employee Rs Th611.13,409.6 17.9%   
Avg. net profit/employee Rs Th803.51,833.8 43.8%   
INCOME DATA
Net Sales Rs m6,635290,659 2.3%  
Other income Rs m24210,255 2.4%   
Total revenues Rs m6,877300,914 2.3%   
Gross profit Rs m1,60463,076 2.5%  
Depreciation Rs m22117,533 1.3%   
Interest Rs m385,553 0.7%   
Profit before tax Rs m1,58750,246 3.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-12,144 0.0%   
Tax Rs m7186,009 11.9%   
Profit after tax Rs m86932,093 2.7%  
Gross profit margin %24.221.7 111.4%  
Effective tax rate %45.212.0 378.2%   
Net profit margin %13.111.0 118.7%  
BALANCE SHEET DATA
Current assets Rs m6,232310,692 2.0%   
Current liabilities Rs m1,490173,396 0.9%   
Net working cap to sales %71.547.2 151.3%  
Current ratio x4.21.8 233.4%  
Inventory Days Days8699 87.3%  
Debtors Days Days83112 74.0%  
Net fixed assets Rs m4,043232,477 1.7%   
Share capital Rs m1272,399 5.3%   
"Free" reserves Rs m8,183411,691 2.0%   
Net worth Rs m8,310414,091 2.0%   
Long term debt Rs m1815,226 0.1%   
Total assets Rs m10,389646,938 1.6%  
Interest coverage x43.110.0 428.9%   
Debt to equity ratio x00 5.8%  
Sales to assets ratio x0.60.4 142.2%   
Return on assets %8.75.8 150.1%  
Return on equity %10.57.8 135.0%  
Return on capital %19.510.2 191.9%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m5,62266,025 8.5%   
Fx outflow Rs m1,79938,610 4.7%   
Net fx Rs m3,82227,415 13.9%   
CASH FLOW
From Operations Rs m35621,965 1.6%  
From Investments Rs m-279-6,813 4.1%  
From Financial Activity Rs m-225-27,305 0.8%  
Net Cashflow Rs m-148-8,442 1.8%  

Share Holding

Indian Promoters % 63.4 63.7 99.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 5.1 -  
FIIs % 0.0 23.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 8.3 439.8%  
Shareholders   37,287 133,026 28.0%  
Pledged promoter(s) holding % 0.0 0.5 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFESCIENCES With:   CIPLA  PIRAMAL ENTERPRISES  NATCO PHARMA  SHASUN PHARMA  PFIZER  

Compare SUVEN LIFESCIENCES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 178 Points Higher; Telecom and Power Stocks Witness Buying(Closing)

Indian share markets witnessed buying interest throughout the day today and ended on a positive note.

Related Views on News

SUN PHARMA Announces Quarterly Results (4QFY20); Net Profit Down 31.6% (Quarterly Result Update)

May 28, 2020 | Updated on May 28, 2020

For the quarter ended March 2020, SUN PHARMA has posted a net profit of Rs 5 bn (down 31.6% YoY). Sales on the other hand came in at Rs 82 bn (up 14.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA Announces Quarterly Results (3QFY20); Net Profit Down 29.8% (Quarterly Result Update)

Feb 7, 2020 | Updated on Feb 7, 2020

For the quarter ended December 2019, SUN PHARMA has posted a net profit of Rs 10 bn (down 29.8% YoY). Sales on the other hand came in at Rs 82 bn (up 5.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

SUN PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 35.3% (Quarterly Result Update)

Aug 14, 2019 | Updated on Aug 14, 2019

For the quarter ended June 2019, SUN PHARMA has posted a net profit of Rs 15 bn (up 35.3% YoY). Sales on the other hand came in at Rs 84 bn (up 15.9% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

Here's an analysis of the annual report of SUN PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

More Views on News

Most Popular

How to Find the Best Stocks for Day Trading - 1(Fast Profits Daily)

Jul 2, 2020

In the first of two videos, I'll show you how to identify the best stocks for intraday trading.

Be Prepared to Profit from the Coming Crash in Oil Prices(Fast Profits Daily)

Jun 25, 2020

The stability in crude oil prices will not last much longer. Be ready to make fast profits when the time comes to short crude.

Tata Motors Tripled in 18 Months but You Can Do Even Better. Here's How...(Profit Hunter)

Jun 24, 2020

Rahul is ready for a repeat of his famous 2008 Tata Motors call.

Two Agri Stocks Are Likely to Outperform Even in this Market(Profit Hunter)

Jul 2, 2020

Why we have recommended two agriculture stocks for our Hidden Treasure subscribers. Read on...

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFESCIENCES SHARE PRICE


Jul 3, 2020 (Close)

TRACK SUVEN LIFESCIENCES

  • Track your investment in SUVEN LIFESCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFESCIENCES

SUVEN LIFESCIENCES 8-QTR ANALYSIS

COMPARE SUVEN LIFESCIENCES WITH

MARKET STATS